| True Reflections Counseling, Llc | |
|
2297 Kansas Ave Se Ste 5 Huron SD 57350-4287 | |
| (605) 212-7326 | |
| Not Available |
| Full Name | True Reflections Counseling, Llc |
|---|---|
| Speciality | Counselor |
| Location | 2297 Kansas Ave Se Ste 5, Huron, South Dakota |
| Authorized Official Name and Position | Kelsi L Stricherz (COUNSELOR) |
| Authorized Official Contact | 6052127326 |
| Accepts Medicare Insurance | Yes. This clinic participates in medicare program and accept medicare insurance. |
| Mailing Address | Practice Location Address |
|---|---|
| True Reflections Counseling, Llc 1845 Iowa Ave Se Huron SD 57350-4031 Ph: (605) 212-7326 | True Reflections Counseling, Llc 2297 Kansas Ave Se Ste 5 Huron SD 57350-4287 Ph: (605) 212-7326 |
| NPI Number | 1942838487 |
|---|---|
| Provider Enumeration Date | 03/30/2020 |
| Last Update Date | 03/30/2020 |
| Certification Date | 03/30/2020 |
| Medicare PECOS PAC ID | 9436520871 |
|---|---|
| Medicare Enrollment ID | O20230124000289 |
News Archive
Individuals who are genetically predisposed to obesity may soon have a therapeutic solution to combat their condition. A research team led by scientists from the National University of Singapore (NUS) has identified several potent inhibitors that selectively target FTO, the common fat mass and obesity-associated gene.
"During the month of May, USAID's "IMPACTblog" "will be highlighting USAID's work in Global Health," the blog notes, adding, "From May 1-10, we will be featuring the role that science, technology and innovation plays in global health."
Alectos Therapeutics Inc. today announced a research collaboration with Merck, headquartered in Whitehouse Station, N.J., to identify and develop compounds that modulate O-linked N-acetylglucosaminidase (O-GlcNAcase) an enzyme that is believed to be involved in the development of Alzheimer's disease and potentially other disorders. The agreement provides Merck with a worldwide, exclusive license to research, develop and commercialize compounds that modulate this target.
Saint Louis University researchers report in Molecular Metabolism new findings that the nuclear receptor REV-ERB appears to play a key role in muscle regeneration, suggesting the receptor may be a good target for new drugs to treat a variety of muscle disorders and injuries.
Researchers from the Johns Hopkins Institute for NanoBioTechnology have been awarded $14.8 million from the National Cancer Institute to launch a research center aimed at unraveling the physical underpinnings of the growth and spread of cancer.
› Verified 4 days ago
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1942838487 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 101YP2500X | Counselor - Professional | (* (Not Available)) | Primary |
| Provider Name | Ashley Frankfurth |
|---|---|
| Provider Type | Practitioner - Clinical Social Worker |
| Provider Identifiers | NPI Number: 1427421452 PECOS PAC ID: 4981996113 Enrollment ID: I20160708001646 |
News Archive
Individuals who are genetically predisposed to obesity may soon have a therapeutic solution to combat their condition. A research team led by scientists from the National University of Singapore (NUS) has identified several potent inhibitors that selectively target FTO, the common fat mass and obesity-associated gene.
"During the month of May, USAID's "IMPACTblog" "will be highlighting USAID's work in Global Health," the blog notes, adding, "From May 1-10, we will be featuring the role that science, technology and innovation plays in global health."
Alectos Therapeutics Inc. today announced a research collaboration with Merck, headquartered in Whitehouse Station, N.J., to identify and develop compounds that modulate O-linked N-acetylglucosaminidase (O-GlcNAcase) an enzyme that is believed to be involved in the development of Alzheimer's disease and potentially other disorders. The agreement provides Merck with a worldwide, exclusive license to research, develop and commercialize compounds that modulate this target.
Saint Louis University researchers report in Molecular Metabolism new findings that the nuclear receptor REV-ERB appears to play a key role in muscle regeneration, suggesting the receptor may be a good target for new drugs to treat a variety of muscle disorders and injuries.
Researchers from the Johns Hopkins Institute for NanoBioTechnology have been awarded $14.8 million from the National Cancer Institute to launch a research center aimed at unraveling the physical underpinnings of the growth and spread of cancer.
› Verified 4 days ago
News Archive
Individuals who are genetically predisposed to obesity may soon have a therapeutic solution to combat their condition. A research team led by scientists from the National University of Singapore (NUS) has identified several potent inhibitors that selectively target FTO, the common fat mass and obesity-associated gene.
"During the month of May, USAID's "IMPACTblog" "will be highlighting USAID's work in Global Health," the blog notes, adding, "From May 1-10, we will be featuring the role that science, technology and innovation plays in global health."
Alectos Therapeutics Inc. today announced a research collaboration with Merck, headquartered in Whitehouse Station, N.J., to identify and develop compounds that modulate O-linked N-acetylglucosaminidase (O-GlcNAcase) an enzyme that is believed to be involved in the development of Alzheimer's disease and potentially other disorders. The agreement provides Merck with a worldwide, exclusive license to research, develop and commercialize compounds that modulate this target.
Saint Louis University researchers report in Molecular Metabolism new findings that the nuclear receptor REV-ERB appears to play a key role in muscle regeneration, suggesting the receptor may be a good target for new drugs to treat a variety of muscle disorders and injuries.
Researchers from the Johns Hopkins Institute for NanoBioTechnology have been awarded $14.8 million from the National Cancer Institute to launch a research center aimed at unraveling the physical underpinnings of the growth and spread of cancer.
› Verified 4 days ago
Community Counseling Service Mental Health Clinic Medicare: Medicare Enrolled Practice Location: 357 Kansas Ave Se, Huron, SD 57350 Phone: 605-352-8596 Fax: 605-352-7001 |